These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11030793)

  • 1. Homocysteine and neurologic disease.
    Diaz-Arrastia R
    Arch Neurol; 2000 Oct; 57(10):1422-7. PubMed ID: 11030793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M;
    Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocysteine and renal disease.
    van Guldener C; Robinson K
    Semin Thromb Hemost; 2000; 26(3):313-24. PubMed ID: 11011849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperhomocysteinemia and the response to vitamin supplementation.
    Ubbink JB; van der Merwe A; Vermaak WJ; Delport R
    Clin Investig; 1993 Dec; 71(12):993-8. PubMed ID: 8124058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia.
    Ubbink JB; Vermaak WJ; van der Merwe A; Becker PJ
    Am J Clin Nutr; 1993 Jan; 57(1):47-53. PubMed ID: 8416664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin requirements for the treatment of hyperhomocysteinemia in humans.
    Ubbink JB; Vermaak WJ; van der Merwe A; Becker PJ; Delport R; Potgieter HC
    J Nutr; 1994 Oct; 124(10):1927-33. PubMed ID: 7931701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease.
    Clarke R; Collins R
    J Cardiovasc Risk; 1998 Aug; 5(4):249-55. PubMed ID: 9919473
    [No Abstract]   [Full Text] [Related]  

  • 9. Hyperhomocysteinemia in organ transplantation.
    Sunder-Plassmann G; Floth A; Födinger M
    Curr Opin Urol; 2000 Mar; 10(2):87-94. PubMed ID: 10785848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
    Clarke R; Armitage J
    Semin Thromb Hemost; 2000; 26(3):341-8. PubMed ID: 11011852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.
    Erzin Y; Uzun H; Celik AF; Aydin S; Dirican A; Uzunismail H
    J Clin Gastroenterol; 2008; 42(5):481-6. PubMed ID: 18344891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels.
    Schnyder G; Roffi M; Pin R; Flammer Y; Lange H; Eberli FR; Meier B; Turi ZG; Hess OM
    N Engl J Med; 2001 Nov; 345(22):1593-600. PubMed ID: 11757505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.
    Jamison RL; Hartigan P; Kaufman JS; Goldfarb DS; Warren SR; Guarino PD; Gaziano JM;
    JAMA; 2007 Sep; 298(10):1163-70. PubMed ID: 17848650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homocysteine and cerebral stroke in developing countries.
    Christopher R; Nagaraja D; Shankar SK
    Curr Med Chem; 2007; 14(22):2393-401. PubMed ID: 17896987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-lowering therapy.
    Yap S; Naughten ER; Wilcken B; Wilcken DE; Boers GH
    Semin Thromb Hemost; 2000; 26(3):335-40. PubMed ID: 11011851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B vitamins and homocysteine in cardiovascular disease and aging.
    Wilcken DE; Wilcken B
    Ann N Y Acad Sci; 1998 Nov; 854():361-70. PubMed ID: 9928444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine trials--clear outcomes for complex reasons.
    Loscalzo J
    N Engl J Med; 2006 Apr; 354(15):1629-32. PubMed ID: 16531615
    [No Abstract]   [Full Text] [Related]  

  • 18. [Homocysteine and cardiovascular risk].
    Auer J; Berent R; Weber T; Lassnig E; Eber B
    Wien Med Wochenschr; 2001; 151(1-2):25-8. PubMed ID: 11234594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild hyperhomocysteinemia is an independent risk factor of arterial vascular disease.
    Boers GH
    Semin Thromb Hemost; 2000; 26(3):291-5. PubMed ID: 11011846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between plasma homocysteine and vitamin status in the Framingham study population. Impact of folic acid fortification.
    Selhub J; Jacques PF; Bostom AG; Wilson PW; Rosenberg IH
    Public Health Rev; 2000; 28(1-4):117-45. PubMed ID: 11411265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.